Body Mass Index and the Risk of Progression of Chronic Kidney Disease

Journal of Renal Nutrition

Volumn 21, Issue 6, 2011, Pages 455-461

  Khedr, Abdelrahman ^a,b   Khedr, Essam ^b   House, Andrew A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BODY MASS; CANADA; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PATHOPHYSIOLOGY; PROTEINURIA; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CANADA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80054962124     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.12.001     Document Type: Article

References (18)

1. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
2. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998, 6(suppl 2):51S-209S.
3. U.S. Renal Data System, USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2008.
4. Goeree R., Manalich J., Grootendorst P., et al. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 1995, 18:455-464.
5. Henegar J.R., Bigler S.A., Henegar L.K., et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001, 12:1211-1217.
6. Hall J.E., Henegar J.R., Dwyer T.M., et al. Is obesity a major cause of chronic kidney disease?. Adv Ren Replace Ther 2004, 11:41-54.
7. Chagnac A., Weinstein T., Korzets A., et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000, 278:F817-F822.
8. de Boer I.H., Sibley S.D., Kestenbaum B., et al. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007, 18:235-243.
9. Levey A.S., Bosch J.P., Lewis J.B., et al. Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470.
10. Ejerblad E., Fored C.M., Lindblad P., et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006, 17:1695-1702.
11. Fox C.S., Larson M.G., Leip E.P., et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291:844-850.
12. Iseki K., Ikemiya Y., Kinjo K., et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004, 65:1870-1876.
13. Yokoyama H., Kanno S., Takahashi S., et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol 2009, 4:1432-1440.
14. Atkins R.C., Briganti E.M., Lewis J.B., et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 2005, 45:281-287.
15. de Zeeuw D., Remuzzi G., Parving H.H., et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004, 65:2309-2320.
16. House A.A., Eliasziw M., Cattran D.C., et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 2010, 303:1603-1609.
17. Levin A., Djurdjev O., Beaulieu M., et al. Variability and risk factors for kidney disease progression and death after attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008, 52:661-671.
18. Ruilope L.M. Angiotensin receptor blockers: RAAS blockade and renoprotection. Curr Med Res Opin 2008, 24:1285-1293.